Interaction of ceruloplasmin and 5-lipoxygenase

被引:0
|
作者
A. V. Sokolov
E. A. Golenkina
V. A. Kostevich
V. B. Vasilyev
G. F. Sud’ina
机构
[1] Research Institute of Experimental Medicine,Belozersky Institute of Physico
[2] Lomonosov Moscow State University,Chemical Biology
来源
Biochemistry (Moscow) | 2010年 / 75卷
关键词
protein-protein interaction; inflammation; leukotrienes; 5-lipoxygenase; ceruloplasmin;
D O I
暂无
中图分类号
学科分类号
摘要
The interaction between ceruloplasmin (CP), the multicopper oxidase of human plasma, and 5-lipoxygenase (5-LO), the key enzyme of leukotriene synthesis, is shown for the first time. By Western-blotting and mass spectrometry of tryptic fragments, it is shown that 5-LO from protein extract of human leukocytes binds with immobilized CP. Dose-dependent influence of intact CP on leukotrienes synthesis is found: CP reduced leukotrienes synthesis in leukocytes in a dose above 50 μg/ml (normal CP concentration in plasma is about 300–400 μg/ml). Proteolyzed CP and apo-form of CP is unable to inhibit activity of 5-LO. CP increased activity of 5-LO at low doses (5–10 μg/ml). On the whole, the influence of CP on phagocytosis index of leukocytes coordinates with influence on activity of 5-LO: the index increased in the range of 2–10 μg/ml CP and decreased at doses of CP above 40 μg/ml. The dual role of CP in regulation of cellular response of leukocytes is discussed.
引用
收藏
页码:1464 / 1469
页数:5
相关论文
共 50 条
  • [1] Interaction of Ceruloplasmin and 5-Lipoxygenase
    Sokolov, A. V.
    Golenkina, E. A.
    Kostevich, V. A.
    Vasilyev, V. B.
    Sud'ina, G. F.
    BIOCHEMISTRY-MOSCOW, 2010, 75 (12) : 1464 - 1469
  • [2] 5-LIPOXYGENASE
    FORDHUTCHINSON, AW
    GRESSER, M
    YOUNG, RN
    ANNUAL REVIEW OF BIOCHEMISTRY, 1994, 63 : 383 - 417
  • [3] Dimerization of human 5-lipoxygenase
    Haefner, Ann-Kathrin
    Cernescu, Mihaela
    Hofmann, Bettina
    Ermisch, Michael
    Hoernig, Michael
    Metzner, Julia
    Schneider, Gisbert
    Brutschy, Bernhard
    Steinhilber, Dieter
    BIOLOGICAL CHEMISTRY, 2011, 392 (12) : 1097 - 1111
  • [4] Characterization of the interaction of human 5-lipoxygenase with its activating protein FLAP
    Haefner, Ann-Kathrin
    Gerstmeier, Jana
    Hoernig, Michael
    George, Sven
    Ball, Ann-Katrin
    Schroeder, Mirjam
    Garscha, Ulrike
    Werz, Oliver
    Steinhilber, Dieter
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2015, 1851 (11): : 1465 - 1472
  • [5] Novel 5-lipoxygenase isoforms affect the biosynthesis of 5-lipoxygenase products
    Boudreau, Luc H.
    Bertin, Jonathan
    Robichaud, Philippe P.
    Laflamme, Mark
    Ouellette, Rodney J.
    Flamand, Nicolas
    Surette, Marc E.
    FASEB JOURNAL, 2011, 25 (03) : 1097 - 1105
  • [6] Therapeutic options for 5-lipoxygenase inhibitors
    Werz, Oliver
    Steinhilber, Dieter
    PHARMACOLOGY & THERAPEUTICS, 2006, 112 (03) : 701 - 718
  • [7] Ablation of 5-lipoxygenase mitigates pancreatic lesion development
    Knab, Lawrence M.
    Schultz, Michelle
    Principe, Daniel R.
    Mascarinas, Windel E.
    Gounaris, Elias
    Munshi, Hidayatullah G.
    Grippo, Paul J.
    Bentrem, David J.
    JOURNAL OF SURGICAL RESEARCH, 2015, 194 (02) : 481 - 487
  • [8] Association of 5-lipoxygenase gene polymorphisms with bronchial asthma
    Bai, Chunying
    Yu, Xiaoming
    Yun, Rui
    Shi, Tiewei
    Zhang, Chaojun
    Zhou, Jing
    Sachurangui
    Tong, Lijuan
    Li, Xiujun
    Gao, Lifeng
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2012, 4 (06) : 967 - 971
  • [9] 5-lipoxygenase and FLAP
    Peters-Golden, M
    Brock, TG
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2003, 69 (2-3): : 99 - 109
  • [10] Arachidonate 5-lipoxygenase
    Rådmark, O
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2002, 68-9 : 211 - 234